Ordering
Available Variants5 mg
CHA.90974-5mg
Price
€87.20
Available – Dispatch in 14 days
25 mg
CHA.90974-25mg
Price
€350.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.90974-5mg | €87.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.90974-25mg | €350.40 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C22H16ClN3O4 |
|---|---|
| CAS Number | 423150-91-8 |
| Molecular Weight | 421.83 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
BAY-4931, also known by its CAS number 247079-84-1, is a synthetic compound that has been investigated for its potential therapeutic applications. This molecule exhibits a distinct chemical structure, which is characterized by a specific arrangement of functional groups and molecular moieties. As a result of its unique chemical properties, BAY-4931 has been studied in various biological contexts, including its potential effects on cellular signaling pathways and its interactions with specific molecular targets. Further research is needed to fully elucidate the mechanisms of action and potential therapeutic uses of BAY-4931, as well as to assess its safety and efficacy in preclinical and clinical settings. The ongoing investigation of BAY-4931 and related compounds may ultimately contribute to the development of novel therapeutic strategies for the treatment of various diseases and disorders. Additional studies are required to fully explore its potential.
